QQ客服 官方微博 反馈留言

	Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety
	Lu, Ying-Feng; Chen, Jian-Yang; Zhang, Yi-Min; Jia, Hong-Yu; Lian, Jiang-Shan; Yang, Yi-Da; Zhang, Zhe; Zhang, Xiao-Lin
刊名	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
	2019
卷号	16期号:1
关键词	ETV LAM and ADV combination therapy de novo switch kidney safety
ISSN号	1449-1907
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3594995
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Lu, Ying-Feng,Chen, Jian-Yang,Zhang, Yi-Min,et al. Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety[J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES,2019,16(1).
APA	Lu, Ying-Feng.,Chen, Jian-Yang.,Zhang, Yi-Min.,Jia, Hong-Yu.,Lian, Jiang-Shan.,...&Zhang, Xiao-Lin.(2019).Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety.INTERNATIONAL JOURNAL OF MEDICAL SCIENCES,16(1).
MLA	Lu, Ying-Feng,et al."Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety".INTERNATIONAL JOURNAL OF MEDICAL SCIENCES 16.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。